Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given for the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, Start Printed Page 26979and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Biomarkers of Autoimmunity in Type 1 Diabetes.
Date: June 14, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review Administrator, Review Branch, DEA, NIDDK, National Institutes of Health, Room 927, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-4719, email@example.com.
(Catalogue of Federal Domestic Assistance Program Nos. 93.947, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Disease, Urology and Hematology Research, National Institutes of Health, HHS)Start Signature
Dated: April 30, 2006.
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-4298 Filed 5-8-06; 8:45am]
BILLING CODE 4140-01-M